Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE
Baker Bros. Advisors LP reported a 9.99% stake in Monte Rosa Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Baker Bros. Advisors LP reported a 9.99% stake in Monte Rosa Therapeutics, Inc., 8,876,346 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 8,876,346
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Baker Bros. Advisors LP | 9.99% | 8,876,346 |
| Baker Bros. Advisors (GP) LLC | 9.99% | 8,876,346 |
| Julian C. Baker | 9.99% | 8,876,346 |
| Felix J. Baker | 9.99% | 8,876,346 |
Source
Related
- Monte Rosa Therapeutics, Inc.
- Baker Bros. Advisors LP
- Monte Rosa Therapeutics, Inc. shareholders
- Schedule 13G/A · Baker Bros. Advisors LP · Feb 17, 2026
- Form 4 · Bowen Matthew · Oct 6, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Aug 14, 2026
- Form 4 · Warmuth Markus · Jul 17, 2026
- Form 4 · Champoux Jennifer · Jul 16, 2026